Itamar Medical (ITMR) KOL Call Highlights How The Company Stands Poised to Benefit From COVID - Cowen
Tweet Send to a Friend
Cowen analyst Joshua Jennings reiterated an Outperform rating and $30.00 price target on Itamar Medical (NASDAQ: ITMR) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
